POINT Biopharma Global Inc.
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand …
Biotechnology
US, Indianapolis [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
POINT Biopharma Global Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPOINT Biopharma Global Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of POINT Biopharma Global Inc..
If you want to see a demo, head over to the financial segments of AAPL